April 2015

10th EFMC Short Course On Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands ( 8:00 am )

10th EFMC Short Course on Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands

In 2009, EFMC launched a series of short courses aimed to favour cultural and scientific growth of the medicinal chemistry community and organized with affordable fees for participation. EFMC will continue the tradition in 2015, and is pleased to announce the following courses:

10th EFMC Short Course on Medicinal Chemistry
Small-Molecule Modulation of Protein-Protein Interactions (PPIs)

Oegstgeest (near Leiden), The Netherlands - April 12-15, 2015

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants will be limited to 35, to favour in depth discussion.

COURSE OUTLINE
Protein-Protein Interactions (PPIs) lie at the heart of almost every physiological process and every disease. With a recently estimated number of 300,000 in humans, the possibilities for therapeutic intervention are significantly larger compared to ‘classical’ drug targets. While this potential is up to now largely untapped, some successful examples have shown that PPIs can be modulated by drug-like small molecules, natural products and peptides.

Specific features of PPIs as drug targets - in comparison to conventionally addressing e.g. enzymes - will be discussed, followed by a broad overview of the field, techniques to discover modulators of PPIs,  and - in more detail - a number of case studies on successful PPI intervention will be presented. Speakers include a selection of top-scientists active in the field of PPI, both from industry and academia.

Course Organisers
Christian OTTMANN and Luc BRUNSVELD (TU Eindhoven, The Netherlands)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.475 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

10th EFMC Short Course On Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands ( 8:00 am )

10th EFMC Short Course on Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands

In 2009, EFMC launched a series of short courses aimed to favour cultural and scientific growth of the medicinal chemistry community and organized with affordable fees for participation. EFMC will continue the tradition in 2015, and is pleased to announce the following courses:

10th EFMC Short Course on Medicinal Chemistry
Small-Molecule Modulation of Protein-Protein Interactions (PPIs)

Oegstgeest (near Leiden), The Netherlands - April 12-15, 2015

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants will be limited to 35, to favour in depth discussion.

COURSE OUTLINE
Protein-Protein Interactions (PPIs) lie at the heart of almost every physiological process and every disease. With a recently estimated number of 300,000 in humans, the possibilities for therapeutic intervention are significantly larger compared to ‘classical’ drug targets. While this potential is up to now largely untapped, some successful examples have shown that PPIs can be modulated by drug-like small molecules, natural products and peptides.

Specific features of PPIs as drug targets - in comparison to conventionally addressing e.g. enzymes - will be discussed, followed by a broad overview of the field, techniques to discover modulators of PPIs,  and - in more detail - a number of case studies on successful PPI intervention will be presented. Speakers include a selection of top-scientists active in the field of PPI, both from industry and academia.

Course Organisers
Christian OTTMANN and Luc BRUNSVELD (TU Eindhoven, The Netherlands)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.475 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

Asthma And COPD 13th April To 14th April 20 15, London, United Kingdom ( 8:00 am )

Asthma and COPD 13th April to 14th April 20 15, London, United Kingdom

Asthma and COPD together create an enormous public health burden and an urgent need for progress in disease understanding, therapy and care. Join us at SMi's 11th annual Asthma & COPD conference to share in the experiences of leading lights in the field who are addressing the challenges of solving the riddle of pathogenesis, biomarkers and endpoints, personalizing therapies vs. the unmet need, tackling the causes and consequences of exacerbations, development of new animal models and better tools for disease diagnosis and monitoring.

 

This conference will give delegates invaluable insights into the key thinking and advances in the respiratory drug market, focusing on the challenges and solutions to enhance patient outcomes, providing extensive knowledge from the key leading industry, academic and care providing experts.

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/asthma-copd

10th EFMC Short Course On Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands ( 8:00 am )

10th EFMC Short Course on Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands

In 2009, EFMC launched a series of short courses aimed to favour cultural and scientific growth of the medicinal chemistry community and organized with affordable fees for participation. EFMC will continue the tradition in 2015, and is pleased to announce the following courses:

10th EFMC Short Course on Medicinal Chemistry
Small-Molecule Modulation of Protein-Protein Interactions (PPIs)

Oegstgeest (near Leiden), The Netherlands - April 12-15, 2015

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants will be limited to 35, to favour in depth discussion.

COURSE OUTLINE
Protein-Protein Interactions (PPIs) lie at the heart of almost every physiological process and every disease. With a recently estimated number of 300,000 in humans, the possibilities for therapeutic intervention are significantly larger compared to ‘classical’ drug targets. While this potential is up to now largely untapped, some successful examples have shown that PPIs can be modulated by drug-like small molecules, natural products and peptides.

Specific features of PPIs as drug targets - in comparison to conventionally addressing e.g. enzymes - will be discussed, followed by a broad overview of the field, techniques to discover modulators of PPIs,  and - in more detail - a number of case studies on successful PPI intervention will be presented. Speakers include a selection of top-scientists active in the field of PPI, both from industry and academia.

Course Organisers
Christian OTTMANN and Luc BRUNSVELD (TU Eindhoven, The Netherlands)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.475 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

Asthma And COPD 13th April To 14th April 20 15, London, United Kingdom ( 8:00 am )

Asthma and COPD 13th April to 14th April 20 15, London, United Kingdom

Asthma and COPD together create an enormous public health burden and an urgent need for progress in disease understanding, therapy and care. Join us at SMi's 11th annual Asthma & COPD conference to share in the experiences of leading lights in the field who are addressing the challenges of solving the riddle of pathogenesis, biomarkers and endpoints, personalizing therapies vs. the unmet need, tackling the causes and consequences of exacerbations, development of new animal models and better tools for disease diagnosis and monitoring.

 

This conference will give delegates invaluable insights into the key thinking and advances in the respiratory drug market, focusing on the challenges and solutions to enhance patient outcomes, providing extensive knowledge from the key leading industry, academic and care providing experts.

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/asthma-copd

10th EFMC Short Course On Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands ( 8:00 am )

10th EFMC Short Course on Medicinal Chemistry April 12-15 2015, Oegstgeest, Netherlands

In 2009, EFMC launched a series of short courses aimed to favour cultural and scientific growth of the medicinal chemistry community and organized with affordable fees for participation. EFMC will continue the tradition in 2015, and is pleased to announce the following courses:

10th EFMC Short Course on Medicinal Chemistry
Small-Molecule Modulation of Protein-Protein Interactions (PPIs)

Oegstgeest (near Leiden), The Netherlands - April 12-15, 2015

This intensive course is intended for scientists working in the field, and the presentations will be given by senior scientists from industry and academia. The number of participants will be limited to 35, to favour in depth discussion.

COURSE OUTLINE
Protein-Protein Interactions (PPIs) lie at the heart of almost every physiological process and every disease. With a recently estimated number of 300,000 in humans, the possibilities for therapeutic intervention are significantly larger compared to ‘classical’ drug targets. While this potential is up to now largely untapped, some successful examples have shown that PPIs can be modulated by drug-like small molecules, natural products and peptides.

Specific features of PPIs as drug targets - in comparison to conventionally addressing e.g. enzymes - will be discussed, followed by a broad overview of the field, techniques to discover modulators of PPIs,  and - in more detail - a number of case studies on successful PPI intervention will be presented. Speakers include a selection of top-scientists active in the field of PPI, both from industry and academia.

Course Organisers
Christian OTTMANN and Luc BRUNSVELD (TU Eindhoven, The Netherlands)

Local Organiser
Henk TIMMERMAN (VU University Amsterdam, The Netherlands)

Registration fee
€1.475 – including accommodation, breakfast, coffee breaks, lunches and dinners during the 3 days of the course

More information on registration can be found on www.efmcshortcourses.org

Url: http://www.efmcshortcourses.org

Adaptive Designs In Clinical Trials 20th April To 21st April 2015, London, United Kingdom ( 8:00 am )

Adaptive Designs in Clinical Trials 20th April to 21st April 2015, London, United Kingdom

Prior to the approval of new drugs, substantial evidence of efficacy is required and safety brought through clinical trials. A massive decline in success rates in Phase II/III of clinical trials has resulted in only 1 in 10 drugs successfully passing  through these trials in the US.

With increasing pressure to bring drugs quickly into the market and reduce the cost of drug development, the paradigms of drug dosage studies in phase II trials and the overall adaptive framework of clinical trials are being increasingly challenged. Thus, strategies such as “Seamless Adaptive Designs” and “Group –Sequential Adaptive Designs” are particular areas that have received a great deal of attention in helping to improve the efficiency of drug development.

This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/adaptive-designs

Controlled Release Conference, 20th - 21st April 2015, London, UK ( 8:00 am )

Controlled Release Conference, 20th - 21st April 2015, London, UK

As controlled release drug delivery systems continue to play an important role among the emerging areas of research in the treatment of diseases, this event will focus on specific topics looking at advances made in the field and how to overcome the challenges involved when developing controlled release formulations.

Returning for its twelfth year and following on from the major success of previous events, SMi are proud to present the 12th annual Controlled Release Conference, 20th - 21st April 2015, London, UK.

Through a series of interactive presentations and panel discussions, the goal of this major networking event is to spotlight principles and illustrative examples facilitating access to the findings of industry innovators on current activities and trends. Ultimately serving as a valuable resource for capturing the ‘big picture’ of the latest research and developments, this is a must attend event!

Key topics include:

• Ocular treatment - the challenge of systemic long term delivery in the eye
• Delivery of therapeutic antibodies… overcoming the technical challenges to add value to the patient whilst ensuring efficacy and stability of the drug
• Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation
• New technology for old drugs! …. Repurposing older drugs for a new generation And much more!

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/controlled-release

Adaptive Designs In Clinical Trials 20th April To 21st April 2015, London, United Kingdom ( 8:00 am )

Adaptive Designs in Clinical Trials 20th April to 21st April 2015, London, United Kingdom

Prior to the approval of new drugs, substantial evidence of efficacy is required and safety brought through clinical trials. A massive decline in success rates in Phase II/III of clinical trials has resulted in only 1 in 10 drugs successfully passing  through these trials in the US.

With increasing pressure to bring drugs quickly into the market and reduce the cost of drug development, the paradigms of drug dosage studies in phase II trials and the overall adaptive framework of clinical trials are being increasingly challenged. Thus, strategies such as “Seamless Adaptive Designs” and “Group –Sequential Adaptive Designs” are particular areas that have received a great deal of attention in helping to improve the efficiency of drug development.

This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/adaptive-designs

Controlled Release Conference, 20th - 21st April 2015, London, UK ( 8:00 am )

Controlled Release Conference, 20th - 21st April 2015, London, UK

As controlled release drug delivery systems continue to play an important role among the emerging areas of research in the treatment of diseases, this event will focus on specific topics looking at advances made in the field and how to overcome the challenges involved when developing controlled release formulations.

Returning for its twelfth year and following on from the major success of previous events, SMi are proud to present the 12th annual Controlled Release Conference, 20th - 21st April 2015, London, UK.

Through a series of interactive presentations and panel discussions, the goal of this major networking event is to spotlight principles and illustrative examples facilitating access to the findings of industry innovators on current activities and trends. Ultimately serving as a valuable resource for capturing the ‘big picture’ of the latest research and developments, this is a must attend event!

Key topics include:

• Ocular treatment - the challenge of systemic long term delivery in the eye
• Delivery of therapeutic antibodies… overcoming the technical challenges to add value to the patient whilst ensuring efficacy and stability of the drug
• Use of solid dispersions to increase the solubility of drugs in terms of controlled release and assimilation
• New technology for old drugs! …. Repurposing older drugs for a new generation And much more!

Url: http://www.smi-online.co.uk/pharmaceuticals/uk/conference/controlled-release

Diabetes Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Diabetes Summit April 27-29, 2015 Boston, MA

GTCbio and the advisory board would like to invite you to the 2015 Diabetes Summit to be held April 27-29, 2015 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

8th Diabetes Drug Discovery & Development Conference

5th Diabetes Partnering & Deal-Making Conference

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

Url: https://www.gtcbio.com/conferences/diabetes-summit-overview

Pre Filled Syringes USA 27th April To 28th April 2015, Iselin, New Jersey, USA ( 8:00 am )

Pre Filled Syringes USA 27th April to 28th April 2015, Iselin, New Jersey, USA

The global prefilled syringe market is estimated to reach $6.9bn by 2018. This figure is reflective of manufacturers striving to improve their technologies to meet the increasing number of biologic drugs reaching the market. The rising demand for prefilled syringes is driving the manufacturers to introduce improvements in technology and with the focus still on the safety for the user, innovation improvements for device development and ease of use for the patient are key areas to be addressed.

SMi’s leading prefilled syringes conference will focus on a number of hot talking points that will no doubt cause controversy and debate and on reflection open the floor to discussion in our breakout sessions. In addition, with a new competitive market just around the corner for biosimilars we look at this new session for 2015 in addition to the vision and benefit of lyophilisation in a prefilled syringe.

Url: http://www.smi-online.co.uk/pharmaceuticals/northamerica/Pre-Filled-Syringes-North-America

Stem Cell Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Stem Cell Summit April 27-29, 2015 Boston, MA

We invite you to attend the Stem Cell Summit 2015 taking place on April 27 - 29, 2015 in Boston, MA at the Hyatt Regency Boston Hotel. This summit includes two parallel conferences which include joint sessions. GTCbio's Stem Cell Summit 2015 provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, product development and business of stem cells.

Discussions on recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, manufacturing and product development will be addressed. Challenges and potential strategies for overcoming these challenges will also be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry? How do you create sustainable business models?

Stem Cell Summit 2015 includes two parallel conferences including joint sessions:

Conference A: Stem Cell Research & Regenerative Medicine
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Cells for Therapeutic Development & Drug Discovery
IV. Advances in Adult & Pluripotent Stem Cells
V. Tissue Engineering
VI. Immunotherapy: Revolution in Cancer Treatments

Conference B: Stem Cell Product Development & Commercialization
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Manufacturing & Product Development
V. Challenges in Developing Clinical Efficacy
VI. Funding Opportunities
VI. Commercialization: Creating Sustainable Business Models

Url: https://www.gtcbio.com/conferences/stem-cell-summit-overview

Diabetes Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Diabetes Summit April 27-29, 2015 Boston, MA

GTCbio and the advisory board would like to invite you to the 2015 Diabetes Summit to be held April 27-29, 2015 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

8th Diabetes Drug Discovery & Development Conference

5th Diabetes Partnering & Deal-Making Conference

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

Url: https://www.gtcbio.com/conferences/diabetes-summit-overview

Pre Filled Syringes USA 27th April To 28th April 2015, Iselin, New Jersey, USA ( 8:00 am )

Pre Filled Syringes USA 27th April to 28th April 2015, Iselin, New Jersey, USA

The global prefilled syringe market is estimated to reach $6.9bn by 2018. This figure is reflective of manufacturers striving to improve their technologies to meet the increasing number of biologic drugs reaching the market. The rising demand for prefilled syringes is driving the manufacturers to introduce improvements in technology and with the focus still on the safety for the user, innovation improvements for device development and ease of use for the patient are key areas to be addressed.

SMi’s leading prefilled syringes conference will focus on a number of hot talking points that will no doubt cause controversy and debate and on reflection open the floor to discussion in our breakout sessions. In addition, with a new competitive market just around the corner for biosimilars we look at this new session for 2015 in addition to the vision and benefit of lyophilisation in a prefilled syringe.

Url: http://www.smi-online.co.uk/pharmaceuticals/northamerica/Pre-Filled-Syringes-North-America

Stem Cell Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Stem Cell Summit April 27-29, 2015 Boston, MA

We invite you to attend the Stem Cell Summit 2015 taking place on April 27 - 29, 2015 in Boston, MA at the Hyatt Regency Boston Hotel. This summit includes two parallel conferences which include joint sessions. GTCbio's Stem Cell Summit 2015 provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, product development and business of stem cells.

Discussions on recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, manufacturing and product development will be addressed. Challenges and potential strategies for overcoming these challenges will also be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry? How do you create sustainable business models?

Stem Cell Summit 2015 includes two parallel conferences including joint sessions:

Conference A: Stem Cell Research & Regenerative Medicine
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Cells for Therapeutic Development & Drug Discovery
IV. Advances in Adult & Pluripotent Stem Cells
V. Tissue Engineering
VI. Immunotherapy: Revolution in Cancer Treatments

Conference B: Stem Cell Product Development & Commercialization
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Manufacturing & Product Development
V. Challenges in Developing Clinical Efficacy
VI. Funding Opportunities
VI. Commercialization: Creating Sustainable Business Models

Url: https://www.gtcbio.com/conferences/stem-cell-summit-overview

Diabetes Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Diabetes Summit April 27-29, 2015 Boston, MA

GTCbio and the advisory board would like to invite you to the 2015 Diabetes Summit to be held April 27-29, 2015 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

8th Diabetes Drug Discovery & Development Conference

5th Diabetes Partnering & Deal-Making Conference

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

Url: https://www.gtcbio.com/conferences/diabetes-summit-overview

Stem Cell Summit April 27-29, 2015 Boston, MA ( 8:00 am )

Stem Cell Summit April 27-29, 2015 Boston, MA

We invite you to attend the Stem Cell Summit 2015 taking place on April 27 - 29, 2015 in Boston, MA at the Hyatt Regency Boston Hotel. This summit includes two parallel conferences which include joint sessions. GTCbio's Stem Cell Summit 2015 provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, product development and business of stem cells.

Discussions on recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, manufacturing and product development will be addressed. Challenges and potential strategies for overcoming these challenges will also be addressed. What categories of companies are currently commercially viable? How are they being funded? What kind of strategic relationships are available within the industry? How do you create sustainable business models?

Stem Cell Summit 2015 includes two parallel conferences including joint sessions:

Conference A: Stem Cell Research & Regenerative Medicine
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Cells for Therapeutic Development & Drug Discovery
IV. Advances in Adult & Pluripotent Stem Cells
V. Tissue Engineering
VI. Immunotherapy: Revolution in Cancer Treatments

Conference B: Stem Cell Product Development & Commercialization
I. Joint Session: Stem Cell Research in the Diabetes Space
II. Joint Session: Stem Cell Therapies from Bench to Bedside
III. Joint Session: Regulatory Guidance
IV. Manufacturing & Product Development
V. Challenges in Developing Clinical Efficacy
VI. Funding Opportunities
VI. Commercialization: Creating Sustainable Business Models

Url: https://www.gtcbio.com/conferences/stem-cell-summit-overview

Lyophilisation & Freeze Drying USA On 29-30 April 2015, Iselin, New Jersey ( 8:00 am )

Lyophilisation & Freeze Drying USA on 29-30 April 2015, Iselin, New Jersey

There’s a growing demand for lyophilised pharmaceutical products that are contributing to an increase in the adoption of lyophilisation equipment and the need for lyophilised biopharmaceuticals and other formulations in the pharmaceutical industry. This is contributing to the projected rise in investment, currently dominated by North America, which is expected to reach $4.80 billion in 2020. This rate of growth is a result of new biologics and biosimilars, enhancing the need for lyophilisation equipment and services.

The requirements governed by the FDA and supported by ISPE focus on improving patient safety and product quality – supporting the adoption of lyophilisation in pharmaceutical manufacturing, with the necessity to lyophilise APIs and various formulations such as antibodies, antiviral drugs, insulin, biosimilars, injections and other therapeutic proteins.

Url: http://www.smi-online.co.uk/goto/2015lyophilisationusa45.asp

Lyophilisation & Freeze Drying USA On 29-30 April 2015, Iselin, New Jersey ( 8:00 am )

Lyophilisation & Freeze Drying USA on 29-30 April 2015, Iselin, New Jersey

There’s a growing demand for lyophilised pharmaceutical products that are contributing to an increase in the adoption of lyophilisation equipment and the need for lyophilised biopharmaceuticals and other formulations in the pharmaceutical industry. This is contributing to the projected rise in investment, currently dominated by North America, which is expected to reach $4.80 billion in 2020. This rate of growth is a result of new biologics and biosimilars, enhancing the need for lyophilisation equipment and services.

The requirements governed by the FDA and supported by ISPE focus on improving patient safety and product quality – supporting the adoption of lyophilisation in pharmaceutical manufacturing, with the necessity to lyophilise APIs and various formulations such as antibodies, antiviral drugs, insulin, biosimilars, injections and other therapeutic proteins.

Url: http://www.smi-online.co.uk/goto/2015lyophilisationusa45.asp